Recruiting
Phase 1

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT05968989

Conditions

Influenza

Eligibility Criteria

Sex: All

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

VRC-FLUMOS0116-00-VP( FLUMos-v2)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information